Developing a faster method to analyze proteins in cancer patients
A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications
This study is testing a new way to quickly and effectively analyze proteins in cancer patients' blood and tissue samples, which could help doctors understand cancer better and provide more accurate information for diagnosis and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11032878 on NIH RePORTER |
What this research studies
This research focuses on creating a new method for analyzing proteins in cancer patients using advanced mass spectrometry techniques. By increasing the speed and efficiency of protein analysis, the goal is to better understand the complexities of cancer at a molecular level. This method aims to significantly enhance the number of proteins that can be analyzed from blood and tissue samples, potentially leading to improved diagnostics and treatment strategies. Patients may benefit from more accurate and timely information about their cancer through this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who are undergoing treatment or evaluation.
Not a fit: Patients with non-cancerous conditions or those who are not undergoing any diagnostic evaluations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate cancer diagnostics, improving treatment outcomes for patients.
How similar studies have performed: Other research has shown promise in using advanced mass spectrometry techniques for proteomics, indicating that this approach could be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Haas, Wilhelm — Massachusetts General Hospital
- Study coordinator: Haas, Wilhelm
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.